Needs and Opportunities for Innovation in Psychopharmacology

Institute of Medicine. Sleeping pills, insomnia, and medical practice. Washington: National Academy of Sciences (USA), 1979

Klerman GL Dimascio A Weissman MM , Treatment of depression by drugs and psychotherapy. Am J Psychiatry 1974; 131: 186–91

Rush AJ Beck AT Kovacs M Hollon S . Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cognitive Therapy Research 1977; 1: 17–37

Langston JW Irwin I Langston EB Forno LS . Pargyline prevents MPTP-induced Parkinsonism in primates. Science 1984; 225: 1480–2

Ballenger JC Post RM . Carbamazepine in manic-depressive illness: A new treatment. Am J Psychiatry 1980; 37: 782–90

Cohen DJ Dethor J Young JG Shaywitz BA . Clonidine ameliorates Gilles de la Tourette Syndrome. Arch Gen Psychiatry 1980; 37: 1350–7

Judd FK Norman TR Burrows GD . Pharmacologic treatment of panic disorder. Int Clin Psychopharmacol 1986; 1: 3–16

Stahl SM . Neuropharmacology of movement disorders: Comparison of spontaneous and drug-induced movement disorders. In: Shah N Donald A , eds. Movement disorders. New York: Plenum, 1986: 1–36

Cooper JR Bloom FE Roth RH . The biochemical basis of neuropharmacology. New York: Oxford University Press, 1982

Iversen LL . Neuropeptides — what next? Trends in Neuroscience 1983; 6: 293–4

Budinger TF Lauterbur PC . Nuclear magnetic resonance technology for medical studies. Science 1984; 226: 288–98

Phelps ME Mazziotta JC . Positron emission tomography: Human brain function and biochemistry. Science 1985; 228: 799–809

Stahl SM Leenders KL Bowery N . Imaging neurotransmitters and their receptors in living human brain by positron emission tomography. Trends in Neuroscience 1986; 9: 241–5

Urquhart J Fara JW Willis KL . Rate-controlled delivery systems in drug and hormone research. Ann Rev Pharmacol Toxicol 1984; 24: 199–236

Hopkins SJ . Drug delivery systems. Drugs of Today 1984; 20: 33–44

Stahl SM . New drug delivery systems — A new approach to Parkinson's disease. In: Marsden CD Trimble M , eds. Future trends in the treatment of Parkinson's disease and epilepsy. London: Franklin Scientific Projects, 1985: 16–18

Freed WJ Ko GN Niehoff DL , Normalization of spiroperidol binding in the denervated rat striatum by homologous grafts of substantia nigra. Science 1983; 222: 937–9

Stahl SM Palazidou L . The pharmacology of depression: Studies of neurotransmitters receptors lead the search for biochemical lesions and new drug therapies. Trends in Pharmacology 1986; 7: 349–54

Johnstone EC Crow TJ Frith CD , The dementia of dementia praecox. Acta Psychiatr Scand 1978; 57: 305–24

Meltzer HY Stahl SM . The dopamine hypothesis of schizophrenia: A review. Schizophr Bull 1976; 2: 19–76

Stahl SM . Tardive dyskinesia; natural history studies assist the pursuit of preventative therapies. Psychol Med 1986; 16: 491–4

Stahl SM Uhr SB Berger PA . Pilot study on the effects of fenfluramine on negative symptoms in twelve schizophrenic inpatients. Biol Psychiatry 1985; 20: 1098–102

Geller E Ritvo ER Freeman BJ Yuwiler A . Preliminary observations on the effect of fenfluramine on blood serotonin and symptoms in three autistic boys. N Engl J Med 1982; 37: 165–9

Peroutka SJ . Selective interaction of novel anxiolytics with 5-hydroxytryptamine 1A receptors. Biol Psychiatry 1985; 20: 971–9

Lee R . Antidepressants and pain: A review of the pharmacological data supporting the use of certain tricyclics in chronic pain. J Int Med Res 1977; 1: 146–66

Hokfelt T Skirboll L Lundberg JM , Neuropeptides and pain pathways. Advances in Pain Research and Therapy 1986; 5: 227–46

Schwarcz R Meldrum B . Excitatory amino acid antagonists provide a therapeutic approach to neurological disorders. Lancet 1985; ii: 140–3